Greater Glasgow and Clyde Medicines

MHRA Drug Safety Update January 2022

Links to the MHRA Drug Safety Update for January 2022 are listed below.

• Brolucizumab (Beovu▼): risk of intraocular inflammation and retinal vascular occlusion increased with short dosing intervals

• Paclitaxel formulations (conventional and nab-paclitaxel): caution required due to potential for medication error

• COVID-19 vaccines and medicines: updates for January 2022

You can sign up to receive these alerts directly from the MHRA at: MHRA email alerts

Published 31/01/2022: Medicines Update blogs are correct at the time of publication.